Ignite Creation Date:
2024-05-05 @ 11:53 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00160004
Status:
TERMINATED
Last Update Posted:
2009-06-08
First Post:
2005-09-09
Brief Title:
The Effect of Intensive Controlled Exercise in the Early Stages of Amyotrophic Lateral Sclerosis
Sponsor:
Radboud University Medical Center
Organization:
Radboud University Medical Center
Study Overview
Official Title:
The Effect of Intensive Controlled Exercise in the Early Stages of Amyotrophic Lateral Sclerosis
Status:
TERMINATED
Status Verified Date:
2009-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
problems with including patients and a large multicenter Trial is now starting as follow-up
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Amyotrophic Lateral Sclerosis ALS is a progressive neurological disorder characterized by amongst others asymmetric muscle weakness respiratory insufficiency and spasticity The disease is usually fatal within 2-3 years and until now there is no cure ALS patients are usually supported by a multidisciplinary team One of the members of this team is the physical therapist The aim of physical therapy might be to enhance or to preserve cardiovascular fitness and muscle strength Some authors suggest however that a moderate to high intensive exercise programme might lead to overuse weakness an undesired fast progression of muscle weakness The primary objective of this study is therefore to investigate whether regular moderate to high intensity exercise program in ALS can maintain or optimize cardiorespiratory fitness and muscle strength A secondary objective is to investigate whether such a programme leads to overuse weakness and if there is a positive influence on patients disability fatigue and quality of life
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None